PTN
Palatin Technologies, Inc. Common Stock
NASDAQ: PTN · HEALTHCARE · BIOTECHNOLOGY
$5.10
+6.92% today
Updated 2026-10-28
Market cap
$9.10M
P/E ratio
—
P/S ratio
0.69x
EPS (TTM)
$-2.96
Dividend yield
—
52W range
$5 – $31
Volume
0.1M
Palatin Technologies, Inc. Common Stock (PTN) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.10
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -63.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.